SG Americas Securities LLC purchased a new stake in Wright Medical Group N.V. (NASDAQ:WMGI) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 63,048 shares of the medical device company’s stock, valued at approximately $1,631,000. SG Americas Securities LLC owned approximately 0.06% of Wright Medical Group as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. FMR LLC boosted its holdings in shares of Wright Medical Group by 5.7% during the 2nd quarter. FMR LLC now owns 15,644,806 shares of the medical device company’s stock valued at $430,075,000 after buying an additional 845,909 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Wright Medical Group by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 8,232,880 shares of the medical device company’s stock valued at $226,321,000 after buying an additional 145,930 shares in the last quarter. Fisher Asset Management LLC boosted its holdings in shares of Wright Medical Group by 20.9% during the 3rd quarter. Fisher Asset Management LLC now owns 2,890,789 shares of the medical device company’s stock valued at $74,785,000 after buying an additional 500,583 shares in the last quarter. Capital Research Global Investors boosted its holdings in shares of Wright Medical Group by 60.9% during the 2nd quarter. Capital Research Global Investors now owns 2,775,000 shares of the medical device company’s stock valued at $76,285,000 after buying an additional 1,050,000 shares in the last quarter. Finally, Palo Alto Investors LLC boosted its holdings in shares of Wright Medical Group by 1.8% during the 2nd quarter. Palo Alto Investors LLC now owns 2,676,393 shares of the medical device company’s stock valued at $73,574,000 after buying an additional 48,200 shares in the last quarter.

In other Wright Medical Group news, Director Richard F. Wallman bought 4,000 shares of the firm’s stock in a transaction on Friday, November 10th. The stock was acquired at an average price of $24.00 per share, with a total value of $96,000.00. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Gregory Morrison sold 92,140 shares of the business’s stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $23.70, for a total value of $2,183,718.00. The disclosure for this sale can be found here. In the last three months, insiders sold 92,440 shares of company stock valued at $2,191,500. 9.30% of the stock is owned by insiders.

Wright Medical Group N.V. (NASDAQ:WMGI) opened at $24.90 on Monday. The company has a debt-to-equity ratio of 1.52, a quick ratio of 0.96 and a current ratio of 1.31. Wright Medical Group N.V. has a 52-week low of $22.14 and a 52-week high of $31.53.

Wright Medical Group (NASDAQ:WMGI) last posted its quarterly earnings results on Wednesday, November 1st. The medical device company reported ($0.16) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.16). The firm had revenue of $170.50 million during the quarter, compared to analyst estimates of $173.50 million. Wright Medical Group had a negative return on equity of 6.27% and a negative net margin of 38.40%. Wright Medical Group’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.19) EPS. equities research analysts predict that Wright Medical Group N.V. will post -0.27 EPS for the current fiscal year.

A number of brokerages have recently commented on WMGI. Barclays PLC dropped their target price on shares of Wright Medical Group from $33.00 to $30.00 and set an “overweight” rating on the stock in a report on Thursday, November 2nd. Jefferies Group LLC restated a “buy” rating and set a $33.00 target price on shares of Wright Medical Group in a report on Friday, August 4th. BidaskClub upgraded shares of Wright Medical Group from a “sell” rating to a “hold” rating in a report on Friday, August 11th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $34.00 price target on shares of Wright Medical Group in a research report on Thursday, August 3rd. Finally, Oppenheimer Holdings, Inc. set a $30.00 price target on Wright Medical Group and gave the stock a “hold” rating in a research report on Thursday, August 3rd. Six research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $32.22.

TRADEMARK VIOLATION WARNING: This news story was reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of United States and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.watchlistnews.com/sg-americas-securities-llc-purchases-shares-of-63048-wright-medical-group-n-v-wmgi/1728610.html.

About Wright Medical Group

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Want to see what other hedge funds are holding WMGI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Wright Medical Group N.V. (NASDAQ:WMGI).

Institutional Ownership by Quarter for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.